Illumina Accelerator

Total investments

43

Average round size

208K

Portfolio companies

39

Rounds per year

4.78

Lead investments

8

Follow on index

0.09

Exits

1

Stages of investment
Seed
Areas of investment
BiotechnologyHealth CareHealth DiagnosticsWellnessGeneticsMedicalTherapeuticsBiopharmaBioinformaticsAgriculture

Summary

Illumina Accelerator is the famous VC, which was founded in 2014. The leading representative office of defined VC is situated in the San Francisco. The venture was found in North America in United States.

The important activity for fund was in 2015. The top amount of exits for fund were in 2018. The common things for fund are deals in the range of 1 - 5 millions dollars. The fund is generally included in less than 2 deals every year. This Illumina Accelerator works on 19 percentage points less the average amount of lead investments comparing to the other organizations.

The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the Illumina Accelerator, startups are often financed by Viking Global Investors, Refactor Capital, Mehdi Maghsoodnia. The meaningful sponsors for the fund in investment in the same round are Viking Global Investors, Refactor Capital, Fall Line Capital. In the next rounds fund is usually obtained by Viking Global Investors, SVG Ventures, Matrix Capital Management.

Among the various public portfolio startups of the fund, we may underline Encoded Therapeutics, Inc., Biome Makers, Vitagene Among the most popular fund investment industries, there are Personalization, Machine Learning. The fund has no exact preference in some founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund.

The fund was created by Amanda Cashin, Mostafa Ronaghi.

Show more

Investments analytics

Analytics

Total investments
43
Lead investments
8
Exits
1
Rounds per year
4.78
Follow on index
0.09
Investments by industry
  • Biotechnology (35)
  • Health Care (18)
  • Therapeutics (11)
  • Bioinformatics (6)
  • Medical (5)
  • Show 23 more
Investments by region
  • United States (24)
  • Canada (1)
  • South Africa (2)
  • United Kingdom (5)
  • Israel (3)
  • Show 5 more
Peak activity year
2021

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
3
Avg. valuation at time of investment
217K
Group Appearance index
0.12
Avg. company exit year
5

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Doloromics 08 Feb 2021 Biotechnology, Health Care, Therapeutics Seed 1M United States, Texas, Dallas
EpiCombi.AI 15 Sep 2021 Biotechnology, Artificial Intelligence, Machine Learning Seed Oxfordshire, Oxford, United Kingdom

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.